Net Cash Provided by (Used in) Financing Activities of DEXCOM INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
DEXCOM INC annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • DEXCOM INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $12,500,000, a 166% increase year-over-year.
  • DEXCOM INC annual Net Cash Provided by (Used in) Financing Activities for 2025 was $1,686,400,000, a 130% decline from 2024.
  • DEXCOM INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $734,800,000, a 131% decline from 2023.
  • DEXCOM INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $318,600,000, a 42% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

DEXCOM INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,686,400,000 -$951,600,000 -130% 01 Jan 2025 31 Dec 2025 10-K 12 Feb 2026 2025 FY
2024 $734,800,000 -$416,200,000 -131% 01 Jan 2024 31 Dec 2024 10-K 12 Feb 2026 2025 FY
2023 $318,600,000 +$233,900,000 +42% 01 Jan 2023 31 Dec 2023 10-K 12 Feb 2026 2025 FY
2022 $552,500,000 -$562,900,000 -5412% 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025 2024 FY
2021 $10,400,000 -$901,700,000 -99% 01 Jan 2021 31 Dec 2021 10-K 08 Feb 2024 2023 FY
2020 $912,100,000 +$901,400,000 +8424% 01 Jan 2020 31 Dec 2020 10-K 09 Feb 2023 2022 FY
2019 $10,700,000 -$699,700,000 -98% 01 Jan 2019 31 Dec 2019 10-K 14 Feb 2022 2021 FY
2018 $710,400,000 +$311,300,000 +78% 01 Jan 2018 31 Dec 2018 10-K 11 Feb 2021 2020 FY
2017 $399,100,000 +$391,000,000 +4827% 01 Jan 2017 31 Dec 2017 10-K 13 Feb 2020 2019 FY
2016 $8,100,000 -$8,700,000 -52% 01 Jan 2016 31 Dec 2016 10-K 21 Feb 2019 2018 FY
2015 $16,800,000 -$5,000,000 -23% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $21,800,000 +$10,000,000 +85% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $11,800,000 +$1,600,000 +16% 01 Jan 2013 31 Dec 2013 10-K 23 Feb 2016 2015 FY
2012 $10,200,000 -$64,000,000 -86% 01 Jan 2012 31 Dec 2012 10-K 25 Feb 2015 2014 FY
2011 $74,200,000 +$4,600,000 +6.6% 01 Jan 2011 31 Dec 2011 10-K 20 Feb 2014 2013 FY
2010 $69,600,000 01 Jan 2010 31 Dec 2010 10-K 21 Feb 2013 2012 FY

DEXCOM INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $12,500,000 +$7,800,000 +166% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $4,700,000 -$6,500,000 -58% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $11,200,000 +$5,900,000 +111% 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024 2024 Q1
Q1 2022 $5,300,000 +$4,500,000 +562% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023 2023 Q1
Q1 2021 $800,000 -$5,700,000 -88% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2022 Q1
Q1 2020 $6,500,000 +$1,600,000 +33% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021 2021 Q1
Q1 2019 $4,900,000 +$700,000 +17% 01 Jan 2019 31 Mar 2019 10-Q 28 Apr 2020 2020 Q1
Q1 2018 $4,200,000 -$76,100,000 -95% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019 2019 Q1
Q1 2017 $80,300,000 +$77,100,000 +2409% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018 2018 Q1
Q1 2016 $3,200,000 -$1,700,000 -35% 01 Jan 2016 31 Mar 2016 10-Q 02 May 2017 2017 Q1
Q1 2015 $4,900,000 -$4,300,000 -47% 01 Jan 2015 31 Mar 2015 10-Q 27 Apr 2016 2016 Q1
Q1 2014 $9,200,000 +$6,500,000 +241% 01 Jan 2014 31 Mar 2014 10-Q 29 Apr 2015 2015 Q1
Q1 2013 $2,700,000 +$1,600,000 +145% 01 Jan 2013 31 Mar 2013 10-Q 01 May 2014 2014 Q1
Q1 2012 $1,100,000 -$363,000 -25% 01 Jan 2012 31 Mar 2012 10-Q 01 May 2013 2013 Q1
Q1 2011 $1,463,000 01 Jan 2011 31 Mar 2011 10-Q 02 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.